Chitinase-3 like-protein-1 function and its role in diseases

T Zhao, Z Su, Y Li, X Zhang, Q You - Signal transduction and targeted …, 2020 - nature.com
Abstract Non-enzymatic chitinase-3 like-protein-1 (CHI3L1) belongs to glycoside hydrolase
family 18. It binds to chitin, heparin, and hyaluronic acid, and is regulated by extracellular …

MicroRNA replacement therapy in cancer

H Mollaei, R Safaralizadeh… - Journal of cellular …, 2019 - Wiley Online Library
Despite the recent progress in cancer management approaches, the mortality rate of cancer
is still growing and there are lots of challenges in the clinics in terms of novel therapeutics …

Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis

Q Lu, Z Ma, YE Ding, T Bedarida, L Chen, Z Xie… - Nature …, 2019 - nature.com
Although angiotensin II (AngII) is known to cause renal injury and fibrosis, the underlying
mechanisms remain poorly characterized. Here we show that hypertensive nephropathy …

Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review

J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik… - Cardiovascular …, 2019 - Springer
In the light of growing global epidemic of type 2 diabetes mellitus (T2DM), significant efforts
are made to discover next-generation biomarkers for early detection of the disease. Multiple …

Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases

IJ Yeo, CK Lee, SB Han, J Yun, JT Hong - Pharmacology & therapeutics, 2019 - Elsevier
Abstract Chitinase 3-like 1 (CHI3L1) is a secreted glycoprotein that mediates inflammation,
macrophage polarization, apoptosis, and carcinogenesis. The expression of CHI3L1 is …

Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives

F Li, A Liu, M Zhao, L Luo - Journal of Neurochemistry, 2023 - Wiley Online Library
Abstract Chitinase‐3‐like protein 1 (CHI3L1) is a secreted glycoprotein characterized by its
ability to regulate multiple biological processes, such as the inflammatory response and …

Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?

X Palomer, J Pizarro-Delgado… - Trends in pharmacological …, 2018 - cell.com
The diabetic heart is characterized by metabolic disturbances that are often accompanied by
local inflammation, oxidative stress, myocardial fibrosis, and cardiomyocyte apoptosis …

Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients

C Napoli, G Benincasa, C Schiano… - European Heart …, 2020 - academic.oup.com
Hyperglycaemia can strongly alter the epigenetic signatures in many types of human
vascular cells providing persistent perturbations of protein–protein interactions both in micro …

Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients

G Mahjoob, Y Ahmadi, H Fatima rajani… - Journal of Clinical …, 2022 - Wiley Online Library
Background Type 2 diabetes mellitus (T2DM) is an increasing metabolic disorder mostly
resulting from unhealthy lifestyles. T2DM patients are prone to develop heart conditions …

Development of novel therapeutic agents by inhibition of oncogenic microRNAs

DD Nguyen, S Chang - International journal of molecular sciences, 2017 - mdpi.com
MicroRNAs (miRs, miRNAs) are regulatory small noncoding RNAs, with their roles already
confirmed to be important for post-transcriptional regulation of gene expression affecting cell …